Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Other Operating Expenses (2009 - 2020)

Danaher (DHR) posted Other Operating Expenses of $400000.0 for Q4 2020, down 99.91% on a QoQ basis from $455.0 million in Q3 2020.

Analysis

Danaher (DHR) Other Operating Expenses (2009 - 2020) Analysis & Trends

Danaher has reported Other Operating Expenses for 3 years, with the latest figure at $400000.0 in Q4 2020.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $400000.0 in Q4 2020; TTM through Oct 2021 was $400000.0, a 99.91% decrease from a year earlier, with the FY2020 full-year figure at $455.0 million, changed N/A from the prior year.
  • Other Operating Expenses was $400000.0 for Q4 2020 at Danaher, down from $455.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $455.0 million in Q3 2020, with the low at $400000.0 in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 400,000.00
Jul 3, 2020 455.00 Mn
Apr 2, 2010 1.61 Bn
Oct 2, 2009 85.12 Mn
Jul 3, 2009 1.41 Bn
Apr 3, 2009 1.37 Bn